Page last updated: 2024-11-06

trenbolone acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Trenbolone Acetate: An anabolic steroid used mainly as an anabolic agent in veterinary practice. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID66359
CHEMBL ID1698011
CHEBI ID192671
SCHEMBL ID139877
MeSH IDM0021871

Synonyms (75)

Synonym
3-oxo-17beta-acetoxyestra-4,9,11-triene
brn 2012395
17beta-hydroxyestra-4,9,11-trien-3-one 17-acetate
trenbolone acetate
component t-s
17-beta-acetoxy-delta-4,9,11-estratrien-3-one
17beta-hydroxyestra-4,9,11-trien-3-one, acetate
17-beta-(acetyloxy)estra-4,9,11-trien-3-one
trienbolone acetate
finaplix
trenbolone acetate, (17beta)-isomer
einecs 233-432-5
ru 1697
17-beta-hydroxyestra-4,9,11-trien-3-one acetate
estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17beta)-
trenbolone acetate [usan]
estra-4,9,11-trien-3-one, 17-beta-hydroxy-, acetate
10161-34-9
finaplix (tn)
trenbolone acetate (usp)
D06211
17 beta-acetoxyestra-4,9,11-trien-3-one
NCGC00167439-01
acetate, trienbolone
acetate, trenbolone
CHEBI:192671
[(8s,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate
finaplix-s
finaplix h
component t-h
unii-rud5y4sv0s
trenbolone acetate [usan:usp]
ru-1697
rud5y4sv0s ,
cas-10161-34-9
dtxsid2046626 ,
tox21_112443
dtxcid0026626
trenbolone acetate ciii
CHEMBL1698011
trenbolone acetate [green book]
trenbolone acetate [usp monograph]
trenbolone acetate [mart.]
trenbolone acetate [usp impurity]
trenbolone acetate [mi]
trenbolone acetate [who-dd]
trenbolone acetate ciii [usp-rs]
AKOS015895158
S4795
HY-12360
CS-3362
trenbolone (acetate)
SCHEMBL139877
trenbolone 17-acetate
estra-4,9,11-trien-3-one, 17-(acetyloxy)-, (17b)-
trenbolone-acetate
trenbolone 17|a-acetate
bdbm50190646
DS-8264
DB14660
(8s,13s,14s,17s)-13-methyl-3-oxo-2,3,6,7,8,13,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl acetate
BCP11574
revalor-h
CCG-267604
NCGC00167439-03
Q27288295
trenbolone-acetate 100 microg/ml in acetonitrile
trenbolone acetate (usan:usp)
trenbolone acetate (usp impurity)
trenbolone acetate (usp monograph)
finaplix-h
trenbolone acetate ciii (usp-rs)
finaplix-h, finaplix-s
trenbolone acetate (mart.)
trenbolone acetate, 1mg/ml in isopropanol

Research Excerpts

Overview

Trenbolone acetate (TBA) is a high-value steroidal growth promoter often administered to beef cattle, whose metabolites are potent endocrine-disrupting compounds. Trenbol one acetate is a synthetic steroid that is exten

ExcerptReferenceRelevance
"Trenbolone acetate (TBA) is a synthetic anabolic steroidal growth factor that is used for rapid muscle development in cattle. "( Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway.
Han, S; Hong, JH; Hwang, MS; Jung, DW; Kang, HS; Koo, YE; Lee, HS; Moon, G; Oh, HS; Park, Y; Suh, JH, 2018
)
1.92
"Trenbolone acetate (TBA) is a high-value steroidal growth promoter often administered to beef cattle, whose metabolites are potent endocrine-disrupting compounds. "( Product-to-parent reversion of trenbolone: unrecognized risks for endocrine disruption.
Baltrusaitis, J; Benchetler, PV; Cole, EA; Cwiertny, DM; Gloer, JB; Jones, GD; Kimbrough, KC; Kolodziej, EP; Long, SA; Patterson, EV; Qu, S; Tarnoff, MD, 2013
)
1.83
"Trenbolone acetate (TBA) is a synthetic anabolic hormone used for growth promotion in beef cattle, which excrete primarily 17alpha-trenbolone along with small amounts of 17beta-trenbolone and trendione. "( Stereoselective sorption by agricultural soils and liquid-liquid partitioning of trenbolone (17alpha and 17beta) and trendione.
Khan, B; Lee, LS; Qiao, X, 2009
)
1.8
"Trenbolone acetate (TBA) is a synthetic androgenic steroid hormone administered as a subcutaneous implant for growth promotion in beef cattle. "( Soil temperature and moisture effects on the persistence of synthetic androgen 17alpha-trenbolone, 17beta-trenbolone and trendione.
Khan, B; Lee, LS, 2010
)
1.8
"Trenbolone acetate (TbA) is a potent synthetic anabolic steroid that was approved by the FDA as a growth promoter in beef cattle in 1987. "( Liquid chromatography-tandem mass spectrometry analysis of 17α-trenbolone, 17β-trenbolone and trendione in airborne particulate matter.
Blackwell, BR; Cai, Q; Cobb, GP; Smith, PN, 2011
)
1.81
"Trenbolone acetate (TbA) is a synthetic growth promoter frequently utilized in beef cattle feeding operations."( Uptake of 17β-trenbolone and subsequent metabolite trendione by the pinto bean plant (Phaseolus vulgaris).
Anderson, TA; Blackwell, BR; Karnjanapiboonwong, A; Smith, PN, 2012
)
1.1
"Trenbolone acetate is an anabolic steroid used to promote growth in beef cattle."( In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant.
Gray, LE; Lambright, C; Ostby, J; Wilson, VS, 2002
)
1.04
"Trenbolone acetate is a synthetic steroid that is extensively used in the United States as a growth promoter in beef cattle. "( Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow.
Ankley, GT; Cardon, MC; Denny, JS; Gray, LE; Hartig, PC; Henry, TR; Hornung, MW; Jensen, KM; Kahl, MD; Korte, JJ; Leino, RL; Makynen, EA; Wilson, VS, 2003
)
1.76
"Trenbolone acetate is a synthetic testosterone analog registered for use in a number of countries as a growth-promoting hormone, applied as an implant in the ears of feedlot cattle. "( Single-laboratory validation of a modified liquid chromatographic method with UV detection for determination of trenbolone residues in bovine liver and muscle.
Fesser, AC; MacNeil, JD; Neiser, CD; Reid, J,
)
1.57
"Trenbolone acetate is a growth promoter widely used for beef production in the U.S. "( Effects of the feedlot contaminant 17alpha-trenbolone on reproductive endocrinology of the fathead minnow.
Ankley, GT; Jensen, KM; Kahl, MD; Makynen, EA, 2006
)
1.78
"Trenbolone acetate is a synthetic anabolic steroid that is widely used in the United States to promote growth of beef cattle."( Identification of metabolites of trenbolone acetate in androgenic runoff from a beef feedlot.
Ankley, GT; Durhan, EJ; Gray, LE; Hartig, PC; Lambright, CS; Lazorchak, J; Makynen, EA; Wilson, VS, 2006
)
1.34
"Trenbolone acetate is a synthetic androgen that is currently used as a growth promoter in many meat-exporting countries. "( Immunotoxicity of trenbolone acetate in Japanese quail.
Lavoie, ET; McKernan, M; Ottinger, MA; Quinn, MJ, 2007
)
2.12

Treatment

ExcerptReferenceRelevance
"Treatment of trenbolone acetate-treated animals with exogenous gonadotrophins suggested that the production of follicle-stimulating hormone had been suppressed."( The action of trenbolone acetate, a synthetic anabolic steroid, on ovarian function in the guinea pig.
Galbraith, H; Hutchinson, JS; Zarkawi, M, 1991
)
0.99

Pharmacokinetics

ExcerptReferenceRelevance
"A single-dose pharmacokinetic (PK) study was conducted."( Studies of the pharmacokinetic profile, in vivo efficacy and safety of injectable altrenogest for the suppression of oestrus in mares.
Colgan, S; Green, LA; McConaghy, FF; Morris, LH, 2016
)
0.43
" The calculated half-life (T ½) of PO administration (7."( Pharmacokinetics of Intrarectal Altrenogest in Horses.
Bailey, CS; Beachler, TM; Council-Troche, RM; Davis, JL; Ellis, KE; Lyle, SK; Von Dollen, KA, 2019
)
0.51

Compound-Compound Interactions

The ultrastructural changes in hepatocytes of steers were studied in animals implanted with 140 mg trenbolone acetate, alone or in combination with 20 mg oestradiol.

ExcerptReferenceRelevance
"The ultrastructural changes in hepatocytes of steers were studied in animals implanted with 140 mg trenbolone acetate, alone or in combination with 20 mg oestradiol."( Effects of the anabolic steroid trenbolone acetate, implanted alone or in combination with oestradiol-17 beta, on liver cell ultrastructure in steers.
Harrison, RD, 1983
)
0.77
"In the first oftwo experiments, 123 calf-fed steers were used over a 2-yr period to evaluate the effects of trenbolone acetate (TBA)-based implants administered alone or in combination with zeranol implants on fresh beef muscle quality, color, and physiological maturity of the carcass."( Effects of implant regimens (trenbolone acetate-estradiol administered alone or in combination with zeranol) and vitamin D3 on fresh beef color and quality.
Johnson, DD; Reiling, BA, 2003
)
0.82

Bioavailability

ExcerptReferenceRelevance
" Bioavailability and toxicological properties of these adducts are discussed."( In vitro metabolism of trenbolone: study of the formation of covalently bound residues.
Evrard, P; Maghuin-Rogister, G,
)
0.13
" The rate of absorption of the agent, which is determined by formulation and site of administration, is most important and is best achieved by the use of slow release implants."( The absorption, distribution and excretion of anabolic agents.
Heitzman, RJ, 1983
)
0.27
" The objective of this study was to determine the fate of 17β-estradiol and 17β-trenbolone in two field sediments and to evaluate the corresponding bioavailability of the compounds to the fathead minnow (Pimephales promelas)."( Bioavailability and fate of sediment-associated trenbolone and estradiol in aquatic systems.
Bartelt-Hunt, SL; Cox, MB; Garcia, YA; Hernandez, R; Kolok, AS; Sangster, JL; Sivils, JC; Snow, DD; Zhang, Y, 2014
)
0.4
"Soil/sediment particle size has been reported to influence the sorption and bioavailability of steroid hormones in the environment."( Impact of sediment particle size on biotransformation of 17β-estradiol and 17β-trenbolone.
Bartelt-Hunt, SL; Gauza, L; Sangster, JL; Zhang, Y, 2016
)
0.43
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Two experiments were conducted at three locations to determine the correct dosage and carrier for trenbolone acetate (TBA) and estradiol (E2) implants in feedlot steers.

ExcerptRelevanceReference
"Two experiments were conducted at three locations to determine the correct dosage and carrier for trenbolone acetate (TBA) and estradiol (E2) implants in feedlot steers."( Trenbolone acetate/estradiol combinations in feedlot steers: dose-response and implant carrier effects.
Bartle, SJ; Brown, RE; Grant, RJ; Preston, RL, 1992
)
1.94
" If applicable, all anabolic agents were found to be present in a variety of esterified dosage forms."( [Anabolic steroid residues in administration sites in slaughtering cattle. October 1983 - January 1985].
Jansen, EH; Stephany, RW; van Blitterswijk, H, 1985
)
0.27
" On 26 March 2003, the male (890293) was started on altrenogest at a dosage of 19."( The use of altrenogest to control aggression in a male Grant's Zebra (Equus burchelli boehmi).
Proudfoot, JS; Ramer, JC; Zehnder, AM, 2006
)
0.33
"05) as the cumulative, combined dosage of E2 plus TBA increased."( Effects of heifer finishing implants on beef carcass traits and longissimus tenderness.
Bryant, TC; Engle, TE; Schneider, BA; Tatum, JD, 2007
)
0.34
" Tetrahydrogestrinone and trenbolone displayed a bell-shaped dose-response curve, with maximal effects observed at 3 and 30 microM, respectively."( Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone.
Bolt, HM; Degen, GH; Diel, P; Dorn, SB; Thevis, M, 2008
)
0.35
"0 microg/l, a solvent control (triethylene glycol, TEG), and a seawater control (SW) using an intermittent flow-through dosing system."( Comparison of estrogen-responsive plasma protein biomarkers and reproductive endpoints in sheepshead minnows exposed to 17beta-trenbolone.
Cripe, GM; Fournie, JW; Goodman, LR; Hemmer, BL; Hemmer, MJ; Salinas, KA; Walker, CC, 2008
)
0.35
" Test concentrations were maintained using an intermittent flow-through dosing apparatus supplying exposure water at 20L/h."( Application of protein expression profiling to screen chemicals for androgenic activity.
Harris, PS; Hemmer, MJ; Salinas, KA, 2011
)
0.37
" In either test system, a potential genotoxic hazard characterized by biphasic dose-response curves could be documented even at exposure concentrations of 30μg/L."( Low-dose effects and biphasic effect profiles: is trenbolone a genotoxicant?
Boettcher, M; Braunbeck, T; Kosmehl, T, 2011
)
0.37
" A first experiment evaluated the effect of a daily 20-mg dosage of ALT during days 1-4 or 2-4 after onset of oestrus on embryo survival at day 42 of pregnancy."( Progestagen supplementation during early pregnancy does not improve embryo survival in pigs.
Bouwman, EG; Hazeleger, W; Jourquin, J; Kemp, B; Langendijk, P; Soede, NM; van der Laan, I, 2012
)
0.38
" In addition to generating data from combined exposure, we fitted these to a four-parametric logistic dose-response model."( Effect of estrogenic binary mixtures in the yeast estrogen screen (YES).
Buechse, A; Dammann, M; Melching-Kollmuß, S; Ramirez, T; van Ravenzwaay, B; Woitkowiak, C, 2014
)
0.4
" To investigate the environmental fate of these compounds and their biotransformation mechanisms, the authors used inocula from a variety of different water sources and dosed biologically active microcosms with approximately 1400 ng/L of trenbolone acetate metabolites, including 17β-trenbolone, trendione, and 17α-trenbolone."( Rates and product identification for trenbolone acetate metabolite biotransformation under aerobic conditions.
Cole, EA; Cwiertny, DM; Kimbrough, KC; Kolodziej, EP; Lee, J; Marchand, EA; McBride, SA, 2015
)
0.87
" A standard safety study was conducted at 1-, 3- and 5-fold the recommended dosage for 84 days."( Studies of the pharmacokinetic profile, in vivo efficacy and safety of injectable altrenogest for the suppression of oestrus in mares.
Colgan, S; Green, LA; McConaghy, FF; Morris, LH, 2016
)
0.43
"We investigated the immunohistochemical expression of progesterone receptors (PRs) in the prostate and bulbourethral glands of thirty-two 10-14-mo-old Charolais bulls following treatment with a low dosage of estrogens."( Semiquantitative immunohistochemical detection of progesterone receptors in male accessory sex glands as a screening assay for anabolic steroid use in bulls.
Biancotto, G; Capello, K; Stella, R; Vascellari, M; Zanardello, C, 2017
)
0.46
" Specific effects of low-level, repeated LPS exposure on the ovary are unclear, as many studies utilize a bolus model and/or high dosage paradigm."( Impact of repeated lipopolysaccharide administration on ovarian signaling during the follicular phase of the estrous cycle in post-pubertal pigs.
Baumgard, LH; Bidne, KL; Keating, AF; Kvidera, SS; Ross, JW, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
steroid ester
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency13.45290.01846.806014.1254AID624172; AID743262
TDP1 proteinHomo sapiens (human)Potency29.85540.000811.382244.6684AID686979
AR proteinHomo sapiens (human)Potency0.85430.000221.22318,912.5098AID743036; AID743040; AID743042; AID743053; AID743054
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.68320.000214.376460.0339AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency2.38290.000229.305416,493.5996AID743075; AID743077; AID743079
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency3.16230.035520.977089.1251AID504332
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency8.08750.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
extracellular regionPolymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1315187Antiviral activity against Influenza A virus A/PR/8/34 (H1N1) infected in MDCK cells assessed as reduction in plaque formation after 2 days by plaque reduction assay2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
AID1315182Binding affinity to PA cavity of recombinant Influenza A virus A/PR/8/34(H1N1) PA (239 to 716 residues) measured after 2 mins by SPR analysis2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (620)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990126 (20.32)18.7374
1990's82 (13.23)18.2507
2000's144 (23.23)29.6817
2010's218 (35.16)24.3611
2020's50 (8.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials62 (9.69%)5.53%
Reviews26 (4.06%)6.00%
Case Studies19 (2.97%)4.05%
Observational0 (0.00%)0.25%
Other533 (83.28%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]